ATOS
Atossa Therapeutics Inc
-7.00%
$0.77 - $0.72
Feb 8th 2023 - Mar 22nd 2023
Dec, 15, 2022
…”, or here is another one, “working on old Morgan... See more
Dec, 11, 2022
$ATOS The Biopharma run gives me renewed hope.
Divihomes is Now Live
A new search platform that matches you with the best home improvement service providers in your area.
Instant Search & Match with Top Contractors
Instant Communication with Local Contractors
Millions of Unbiased User Reviews
100% Free Quotes from Top-Notch Contractors
AKBA
Akebia Therapeutics Inc.
-38.05%
$1.13 - $0.70
Feb 7th 2023 - Mar 21st 2023
Jan, 22, 2023
butler, ceo of akebia therapeutics, exuded confide... See more
Dec, 19, 2022
This results in a cash per share ratio of 0.78, wh... See more
No reviews available.
Dec, 15, 2022
…”, or here is another one, “working on old Morgans is therapeutic — it’s hands-on and good for the soul.” May Atossa Therapeutic success and benefits are obvious.
Dec, 11, 2022
$ATOS The Biopharma run gives me renewed hope.
Jan, 22, 2023
butler, ceo of akebia therapeutics, exuded confidence about his company’s prospects in the coming year.
Dec, 19, 2022
This results in a cash per share ratio of 0.78, which makes it an attractive takeover target, given it will continue generating positive cash flow.” Akebia Therapeutics - well positioned to exploit volatility, financially stable, positive cash flow.
Oct, 20, 2022
Akebia Therapeutics @akebiatx 2h An evening celebrating the dedication and persistence of those in the #kidney community is an evening well spent.